
Mary Mosher
Examiner (ID: 10578)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1641, 1805, 2899, 1813, 1648, 1804, 1643, 1815, 1609 |
| Total Applications | 1434 |
| Issued Applications | 907 |
| Pending Applications | 126 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 314534
[patent_doc_number] => 07524503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/482284
[patent_app_country] => US
[patent_app_date] => 2002-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 34925
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524503.pdf
[firstpage_image] =>[orig_patent_app_number] => 10482284
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/482284 | Human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor | Jun 25, 2002 | Issued |
Array
(
[id] => 891615
[patent_doc_number] => 07344872
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Method for rapid screening of bacterial transformants and novel simian adenovirus proteins'
[patent_app_type] => utility
[patent_app_number] => 10/477527
[patent_app_country] => US
[patent_app_date] => 2002-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19906
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/344/07344872.pdf
[firstpage_image] =>[orig_patent_app_number] => 10477527
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477527 | Method for rapid screening of bacterial transformants and novel simian adenovirus proteins | Jun 19, 2002 | Issued |
Array
(
[id] => 6693169
[patent_doc_number] => 20030040601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Method for making insulin precursors and insulin analog precursors'
[patent_app_type] => new
[patent_app_number] => 10/166241
[patent_app_country] => US
[patent_app_date] => 2002-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6270
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040601.pdf
[firstpage_image] =>[orig_patent_app_number] => 10166241
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/166241 | Method for making insulin precursors and insulin analog precursors | Jun 6, 2002 | Abandoned |
Array
(
[id] => 6905487
[patent_doc_number] => 20050100882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'CAPPING ENZYME OF FLAVIVIRUS AND UTILIZATION OF THIS PROTEIN IN A PROCESS TO TEST DRUGS WITH ANTIVIRAL PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 10/160821
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6905
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100882.pdf
[firstpage_image] =>[orig_patent_app_number] => 10160821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/160821 | Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties | May 30, 2002 | Issued |
Array
(
[id] => 6744622
[patent_doc_number] => 20030021805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Generation of HCV-like particles and chimeric HCV virus'
[patent_app_type] => new
[patent_app_number] => 10/156647
[patent_app_country] => US
[patent_app_date] => 2002-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6921
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20030021805.pdf
[firstpage_image] =>[orig_patent_app_number] => 10156647
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/156647 | Generation of HCV-like particles and chimeric HCV virus | May 28, 2002 | Abandoned |
Array
(
[id] => 5743099
[patent_doc_number] => 20060088824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Wnv core protein/capsid interacting protein and uses of the same'
[patent_app_type] => utility
[patent_app_number] => 10/478743
[patent_app_country] => US
[patent_app_date] => 2002-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5594
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478743
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478743 | WNV core protein/capsid interacting protein and uses of the same | May 27, 2002 | Issued |
Array
(
[id] => 6778183
[patent_doc_number] => 20030049264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Clostridial toxin derivatives able to modify peripheral sensory afferent functions'
[patent_app_type] => new
[patent_app_number] => 10/150262
[patent_app_country] => US
[patent_app_date] => 2002-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8734
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049264.pdf
[firstpage_image] =>[orig_patent_app_number] => 10150262
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/150262 | Clostridial toxin derivatives able to modify peripheral sensory afferent functions | May 19, 2002 | Issued |
Array
(
[id] => 6688311
[patent_doc_number] => 20030032036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Novel bacteriophage, a process for the islolation thereof, and a universal growth medium useful in the process thereof'
[patent_app_type] => new
[patent_app_number] => 10/144457
[patent_app_country] => US
[patent_app_date] => 2002-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11755
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10144457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/144457 | Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof | May 12, 2002 | Issued |
Array
(
[id] => 6687958
[patent_doc_number] => 20030031683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Recombinant vaccines comprising immunogenic attenuated bacteria having RpoS positive phenotype'
[patent_app_type] => new
[patent_app_number] => 10/138239
[patent_app_country] => US
[patent_app_date] => 2002-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 32874
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138239
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138239 | Recombinant vaccines comprising immunogenic attenuated bacteria having RpoS positive phenotype | May 2, 2002 | Issued |
Array
(
[id] => 1311346
[patent_doc_number] => 06610474
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Cells for detection of influenza and parainfluenza viruses'
[patent_app_type] => B1
[patent_app_number] => 10/133910
[patent_app_country] => US
[patent_app_date] => 2002-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13204
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610474.pdf
[firstpage_image] =>[orig_patent_app_number] => 10133910
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/133910 | Cells for detection of influenza and parainfluenza viruses | Apr 24, 2002 | Issued |
Array
(
[id] => 718840
[patent_doc_number] => 07048930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Expression of core-glycosylated HCV envelope proteins in yeast'
[patent_app_type] => utility
[patent_app_number] => 10/128578
[patent_app_country] => US
[patent_app_date] => 2002-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 34128
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/048/07048930.pdf
[firstpage_image] =>[orig_patent_app_number] => 10128578
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/128578 | Expression of core-glycosylated HCV envelope proteins in yeast | Apr 23, 2002 | Issued |
Array
(
[id] => 6765532
[patent_doc_number] => 20030099931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Prophylactic and therapeutic monoclonal antibodies'
[patent_app_type] => new
[patent_app_number] => 10/127641
[patent_app_country] => US
[patent_app_date] => 2002-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7966
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099931.pdf
[firstpage_image] =>[orig_patent_app_number] => 10127641
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/127641 | Prophylactic and therapeutic monoclonal antibodies | Apr 21, 2002 | Issued |
Array
(
[id] => 1166086
[patent_doc_number] => 06752995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-22
[patent_title] => 'Nucleic acid and polypeptide sequences useful as adjuvants'
[patent_app_type] => B2
[patent_app_number] => 10/123058
[patent_app_country] => US
[patent_app_date] => 2002-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15812
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/752/06752995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10123058
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/123058 | Nucleic acid and polypeptide sequences useful as adjuvants | Apr 14, 2002 | Issued |
Array
(
[id] => 307115
[patent_doc_number] => 07531180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-12
[patent_title] => 'Chimeric alphavirus replicon particles'
[patent_app_type] => utility
[patent_app_number] => 10/123101
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 12
[patent_no_of_words] => 30593
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/531/07531180.pdf
[firstpage_image] =>[orig_patent_app_number] => 10123101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/123101 | Chimeric alphavirus replicon particles | Apr 10, 2002 | Issued |
Array
(
[id] => 6643017
[patent_doc_number] => 20030104008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Recombinant vaccine against west nile virus'
[patent_app_type] => new
[patent_app_number] => 10/116298
[patent_app_country] => US
[patent_app_date] => 2002-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14240
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10116298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/116298 | Recombinant vaccine against west nile virus | Apr 3, 2002 | Abandoned |
Array
(
[id] => 1132534
[patent_doc_number] => 06783759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-31
[patent_title] => 'Compositions and methods for modulating variola virus'
[patent_app_type] => B2
[patent_app_number] => 10/108311
[patent_app_country] => US
[patent_app_date] => 2002-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10102
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/783/06783759.pdf
[firstpage_image] =>[orig_patent_app_number] => 10108311
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/108311 | Compositions and methods for modulating variola virus | Mar 26, 2002 | Issued |
Array
(
[id] => 633861
[patent_doc_number] => 07128916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-31
[patent_title] => 'Bacteriophage-mediated immunisation'
[patent_app_type] => utility
[patent_app_number] => 10/473664
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 6539
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/128/07128916.pdf
[firstpage_image] =>[orig_patent_app_number] => 10473664
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/473664 | Bacteriophage-mediated immunisation | Mar 24, 2002 | Issued |
Array
(
[id] => 6048033
[patent_doc_number] => 20020168760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Retroviral vectors for gene transfer into neuronal cells'
[patent_app_type] => new
[patent_app_number] => 10/097556
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5872
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168760.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097556 | Retroviral vectors for gene transfer into neuronal cells | Mar 12, 2002 | Abandoned |
Array
(
[id] => 7405713
[patent_doc_number] => 20040105871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Compositions and methods for generating an immune response'
[patent_app_type] => new
[patent_app_number] => 10/093953
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 76
[patent_figures_cnt] => 76
[patent_no_of_words] => 29682
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20040105871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10093953
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/093953 | Compositions and methods for generating an immune response | Mar 7, 2002 | Abandoned |
Array
(
[id] => 7323976
[patent_doc_number] => 20040137599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Leporipox-based vector vaccines'
[patent_app_type] => new
[patent_app_number] => 10/471300
[patent_app_country] => US
[patent_app_date] => 2003-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7904
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137599.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471300 | Leporipox-based vector vaccines | Mar 6, 2002 | Issued |